GlobeNewswire 06/03/2024 ADC Therapeutics to Host Fourth Quarter and Year-End 2023 Financial Results Conference Call on March...
GlobeNewswire 05/03/2024 ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cance...
GlobeNewswire 04/01/2024 ADC Therapeutics Regains Compliance with NYSE Continued Listing Standards
GlobeNewswire 04/01/2024 ADC Therapeutics Provides Business Updates
GlobeNewswire 12/12/2023 ADC Therapeutics Announces Initial Results from Investigator-Initiated Phase 2 Clinical Trial Evalua...
GlobeNewswire 07/11/2023 ADC Therapeutics Receives NYSE Notice of Non-Compliance With Continued Listing Standards
GlobeNewswire 07/11/2023 ADC Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates
GlobeNewswire 06/11/2023 Health Canada Approves DOPTELET (avatrombopag) for Two Indications in Thrombocytopenia
GlobeNewswire 06/11/2023 ADC Therapeutics to Participate in the Jefferies London Healthcare Conference
GlobeNewswire 02/11/2023 Galapagos reports third quarter 2023 results and releases new encouraging data from CAR-T studies fo...
GlobeNewswire 02/11/2023 ADC Therapeutics Announces Abstracts Accepted for Presentation at the 65th ASH Annual Meeting
GlobeNewswire 01/11/2023 Sensei Biotherapeutics Appoints Stephanie Krebs, MS, MBA, as Chief Business Officer
GlobeNewswire 31/10/2023 Selecta Announces Transition of Manufacturing and Clinical Operations of ImmTOR for SEL-212 to Comme...
GlobeNewswire 24/10/2023 ADC Therapeutics to Host Third Quarter 2023 Financial Results Conference Call on November 7, 2023
GlobeNewswire 05/09/2023 ADC Therapeutics to Participate in September Investor Conferences
GlobeNewswire 31/08/2023 ADC Therapeutics Announces Updates on ZYNLONTA® LOTIS Clinical Trial Programs at the Eleventh Annual...
Newsfile Corp 23/08/2023 SEC Charges Former Attorney at U.S.-Based Global Law Firm with Insider Trading
GlobeNewswire 17/08/2023 Selecta Biosciences Reports Second Quarter 2023 Financial Results and Updates on Strategic Initiativ...
GlobeNewswire 28/03/2022 Apellis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Op...
GlobeNewswire 10/03/2022 Selecta Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Busines...
GlobeNewswire 09/03/2022 Efanesoctocog alfa met primary and key secondary endpoints in pivotal study in hemophilia A, demonst...
GlobeNewswire 11/01/2022 Avalo Therapeutics Appoints Stephen Smolinski as Chief Commercial Officer
GlobeNewswire 22/12/2021 Pharvaris Announces Changes to its Board of Directors
GlobeNewswire 15/12/2021 Apellis and Sobi Announce EU Approval of Aspaveli® (pegcetacoplan) for Treatment of PNH
GlobeNewswire 13/12/2021 Apellis and Sobi Report Empaveli™ (pegcetacoplan) Demonstrated Sustained Normalization of Clinical M...